Gynesonic Names Industry veteran skip baldino president and ceo, announces $25M financing to expand worldwide commercialization April 11, 2023 Read More ›
Thryv Therapeutics Inc. Announces Completion of Initial Phase 1 Clinical Study and Beginning of Proof of Efficacy Study in Long QT Syndrome March 14, 2023 Read More ›
Contego Medical Completes Enrollment of the PERFORMANCE II Carotid Stent Trial November 14, 2022 Read More ›
Neuros Medical Announces Completion of QUEST Pivotal Trial 90-day Primary Endpoints June 6, 2022 Read More ›
